We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HCA Healthcare (HCA) Beats on Q2 Earnings, Revenues
Read MoreHide Full Article
Have you been eager to see how HCA Healthcare, Inc. (HCA - Free Report) performed in Q2 in comparison with the market expectations?
Let’s quickly scan through the key facts from this leading hospital company’s earnings release this morning.
Earnings Beat Estimates
HCA Healthcare came out with adjusted earnings per share of $2.31, beating the Zacks Consensus Estimate of $2.14. Earnings shot up nearly 32% year over year.
How Was the Estimate Revision Trend?
You should note that the earnings estimate for HCA Healthcare depicted neutral stance prior to the earnings release. The Zacks Consensus Estimate remained unchanged at $2.14 per share over the last 7 days.
HCA Healthcare posted revenues of $11.5 billion, beating Zacks Consensus Estimate of $11.3 billion. The reported figure was up from 7.4% from the year-ago quarter.
Key Stats to Note
Adjusted EBITDA totaled $ $2.2 billion, up 6.6% year over year.
Same facility equivalent admissions increased 2.8% year over year, while same facility admissions increased 2.7%. Same facility revenue per equivalent admission increased 3.6%.
Expenses increased nearly 8% year over year to $9.3 billion.
As of June 30, 2018, HCA operated 178 hospitals and approximately 1,800 sites of care including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics.
The company bought back 4.67 million shares for $470 million.
Guidance Unchanged
The expects 2018 revenues in the range of $4.55 billion-$46.5 billion, adjusted EBIDTA of $8.65–$8.85 billion, EPS of $9.00–$9.40 and capital expenditures of about $3.5 billion.
What Zacks Rank Says
HCA Healthcare carries a Zacks Rank #2 (Buy). However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change.
Check back later for our full write up on this HCA Healthcare earnings report!
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Image: Bigstock
HCA Healthcare (HCA) Beats on Q2 Earnings, Revenues
Have you been eager to see how HCA Healthcare, Inc. (HCA - Free Report) performed in Q2 in comparison with the market expectations?
Let’s quickly scan through the key facts from this leading hospital company’s earnings release this morning.
Earnings Beat Estimates
HCA Healthcare came out with adjusted earnings per share of $2.31, beating the Zacks Consensus Estimate of $2.14. Earnings shot up nearly 32% year over year.
How Was the Estimate Revision Trend?
You should note that the earnings estimate for HCA Healthcare depicted neutral stance prior to the earnings release. The Zacks Consensus Estimate remained unchanged at $2.14 per share over the last 7 days.
HCA Healthcare, Inc. Price and EPS Surprise
HCA Healthcare, Inc. Price and EPS Surprise | HCA Healthcare, Inc. Quote
Revenue Beat Estimates
HCA Healthcare posted revenues of $11.5 billion, beating Zacks Consensus Estimate of $11.3 billion. The reported figure was up from 7.4% from the year-ago quarter.
Key Stats to Note
Adjusted EBITDA totaled $ $2.2 billion, up 6.6% year over year.
Same facility equivalent admissions increased 2.8% year over year, while same facility admissions increased 2.7%. Same facility revenue per equivalent admission increased 3.6%.
Expenses increased nearly 8% year over year to $9.3 billion.
As of June 30, 2018, HCA operated 178 hospitals and approximately 1,800 sites of care including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics.
The company bought back 4.67 million shares for $470 million.
Guidance Unchanged
The expects 2018 revenues in the range of $4.55 billion-$46.5 billion, adjusted EBIDTA of $8.65–$8.85 billion, EPS of $9.00–$9.40 and capital expenditures of about $3.5 billion.
What Zacks Rank Says
HCA Healthcare carries a Zacks Rank #2 (Buy). However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change.
You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
Check back later for our full write up on this HCA Healthcare earnings report!
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>